[EN] BRIDGED COMPOUNDS AS KRAS G12D INHIBITOR AND DEGRADER AND THE USE THEREOF<br/>[FR] COMPOSÉS PONTÉS EN TANT QU'INHIBITEUR ET DÉGRADEUR DE KRAS G12D ET LEUR UTILISATION
申请人:BEIGENE LTD
公开号:WO2022148421A1
公开(公告)日:2022-07-14
Provided are bridged compounds as well as their compositions and methods of use. The compounds disclosed herein inhibit KRAS G12D activity and are useful in the treatment of various diseases including cancer.
提供了桥接化合物及其组成和使用方法。本文所披露的化合物抑制KRAS G12D活性,并可用于治疗包括癌症在内的各种疾病。